Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
P.Ø. Jensen, S.A. Møller, C.J. Lerche, C. Moser, T. Bjarnsholt, O. Ciofu, D. Faurholt-Jepsen, N. Høiby, M. Kolpen
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Micro-environmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response
10.1111/apm.12668 · 2017
Diagnosis of biofilm infections in cystic fibrosis patients
10.1111/apm.12689 · 2017
Antimicrobial resistance in cystic fibrosis international working G. Defining antimicrobial resistance in cystic fibrosis
10.1016/j.jcf.2018.08.014 · 2018
Antimicrobial resistance in cystic fibrosis international working G. Antimicrobial resistance in cystic fibrosis: does it matter?
10.1016/j.jcf.2018.08.015 · 2018
Antimicrobial Resistance in Cystic Fibrosis InternationalWorking G. Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review
10.1016/j.jcf.2019.01.008 · 2019
The clinical impact of bacterial biofilms
10.4248/ijos11026 · 2011
Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model
10.1093/jac/dkv058 · 2015
Diffusion retardation by binding of tobramycin in an alginate biofilm model
10.1371/journal.pone.0153616 · 2016
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1002/ppul.21011 · 2009
Biofilms and host response - helpful or harmful
10.1111/apm.12674 · 2017
Pseudomonas aeruginosa aggregate formation in an alginate bead model system exhibits in vivo-like characteristics
10.1128/aem.00113-17 · 2017
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients
10.1016/j.jcf.2014.09.013 · 2015
Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection
10.1002/ppul.21350 · 2011
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?
2018
Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions
10.4049/jimmunol.171.8.4329 · 2003
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients
10.1172/jci0213870 · 2002
Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
10.1371/journal.pone.0084353 · 2014
Pediatric cystic fibrosis sputum can Be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation
10.1128/mbio.00767-15 · 2015
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin
10.1128/aac.47.1.317-323.2003 · 2003
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms
10.1128/aac.48.7.2659-2664.2004 · 2004
Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis
10.1136/thx.2009.114512 · 2010
Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen
10.1111/cei.12318 · 2014
Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes
10.1002/jlb.58.5.616 · 1995
Bacterial infection induces nitric oxide synthase in human neutrophils
10.1172/jci119121 · 1997
In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients
10.1128/iai.01807-06 · 2007
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis
10.1086/599360 · 2009
Cell biology and molecular basis of denitrification
1997
Denitrification and aerobic respiration, hybrid electron transport chains and co-evolution
10.1016/j.bbabio.2012.10.002 · 2013
Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients
10.1128/iai.01969-14 · 2014
Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
10.3389/fmicb.2014.00554 · 2014
Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum
10.1073/pnas.1512057112 · 2016
Exposing the three-dimensional biogeography and metabolic states of pathogens in cystic fibrosis sputum via hydrogel embedding, clearing, and rRNA labeling
10.1128/mbio.00796-16 · 2016
The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth
1986
Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate
10.1093/jac/27.2.177 · 1991
The role of reactive oxygen species in antibiotic-mediated killing of bacteria
10.1016/j.tim.2016.12.008 · 2017
Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation
10.1016/j.ijantimicag.2013.10.015 · 2014
Antibiotics induce redox-related physiological alterations as part of their lethality
10.1073/pnas.1401876111 · 2014
Antibiotic efficacy is linked to bacterial cellular respiration
10.1073/pnas.1509743112 · 2015
Antimicrobial tolerance and metabolic adaptations in microbial biofilms
10.1016/j.tim.2019.05.003 · 2019
Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa
10.1128/aac.00493-13 · doi-reference
Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis
10.1016/j.molcel.2010.01.003 · doi-reference
A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits
10.1093/infdis/142.6.915 · doi-reference
Is hyperbaric oxygen or ozone effective in experimental endocarditis?
10.1016/j.jss.2015.12.006 · doi-reference
Hyperbaric oxygen therapy as an adjunctive treatment for sternal infection and osteomyelitis after sternotomy and cardiothoracic surgery
10.1186/1749-8090-6-141 · doi-reference
Hyperbaric oxygen therapy as adjuvant treatment for hardware-related infections in neuromodulation
10.1159/000486684 · doi-reference
Hyperbaric oxygen therapy in spontaneous brain abscess patients: a population-based comparative cohort study
10.1007/s00701-016-2809-1 · doi-reference
Hyperbaric oxygen therapy: side effects defined and quantified
10.1089/wound.2016.0718 · doi-reference
Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms
10.1371/journal.pone.0198909 · doi-reference
Hyperbaric oxygen therapy augments tobramycin efficacy in experimental Staphylococcus aureus endocarditis
10.1016/j.ijantimicag.2017.04.025 · doi-reference
Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms
10.1111/2049-632x.12120 · doi-reference
Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients
10.1016/j.jcf.2019.01.005 · doi-reference
Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment
10.1016/j.ijantimicag.2015.12.005 · doi-reference